Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer
Clinical trial NCT06587789 · RECRUITING
Trial details
- NCT number
- NCT06587789
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-01
- Primary completion
- 2026-01-01
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.